重度泛发性隐性营养不良性大疱性表皮松解症患者在接受西妥昔单抗抗癌治疗时的伤口愈合缺陷 - Suppr

Suppr

超能文献

Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.

作者信息

Medek Katharina, Koelblinger Peter, Koller Josef, Diem Anja, Ude-Schoder Katharina, Bauer Johann W, Laimer Martin

机构信息

Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.

EB House Austria, University Hospital of Dermatology of the Paracelsus Medical University, Salzburg, Austria.

出版信息

J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.

DOI:10.1111/ddg.13802

PMID:30821421

Abstract

摘要

相似文献

Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.

J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.

Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.

Acta Derm Venereol. 2001 Jun-Jul;81(3):189-92. doi: 10.1080/000155501750376285.

Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e1-e3. doi: 10.1111/jdv.15835. Epub 2019 Sep 2.

Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.

Int J Dermatol. 2009 Jul;48(7):731-3. doi: 10.1111/j.1365-4632.2009.03910.x.

Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.

J Dtsch Dermatol Ges. 2023 Mar;21(3):295-297. doi: 10.1111/ddg.14980. Epub 2023 Feb 28.

[Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].

Ann Dermatol Venereol. 1992;119(8):563-5.

Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.

Clin Exp Dermatol. 2003 Mar;28(2):163-6. doi: 10.1046/j.1365-2230.2003.01185.x.

Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.

Br J Dermatol. 2013 Jul;169(1):208-10. doi: 10.1111/bjd.12272.

Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.

Int J Dermatol. 2009 Jun;48(6):588-91. doi: 10.1111/j.1365-4632.2009.04006.x.

Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.

Acta Derm Venereol. 2003;83(3):225-6. doi: 10.1080/00015550310007283.

引用本文的文献

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.

Orphanet J Rare Dis. 2024 May 21;19(1):206. doi: 10.1186/s13023-024-03190-1.

Integrated Management Strategies for Epidermolysis Bullosa: Current Insights.

Int J Gen Med. 2022 May 24;15:5133-5144. doi: 10.2147/IJGM.S342740. eCollection 2022.

Transcriptome-Guided Drug Repurposing for Aggressive SCCs.

Int J Mol Sci. 2022 Jan 17;23(2):1007. doi: 10.3390/ijms23021007.

Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.

Acta Derm Venereol. 2021 Aug 24;101(8):adv00523. doi: 10.2340/00015555-3875.

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa.

Orphanet J Rare Dis. 2019 Dec 3;14(1):278. doi: 10.1186/s13023-019-1262-7.

Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Int J Mol Sci. 2019 Nov 14;20(22):5707. doi: 10.3390/ijms20225707.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.

作者信息

Medek Katharina, Koelblinger Peter, Koller Josef, Diem Anja, Ude-Schoder Katharina, Bauer Johann W, Laimer Martin

机构信息

Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.

EB House Austria, University Hospital of Dermatology of the Paracelsus Medical University, Salzburg, Austria.

出版信息

J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.

DOI:10.1111/ddg.13802

PMID:30821421

Abstract

摘要

相似文献

Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.

J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.

Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.

Acta Derm Venereol. 2001 Jun-Jul;81(3):189-92. doi: 10.1080/000155501750376285.

Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e1-e3. doi: 10.1111/jdv.15835. Epub 2019 Sep 2.

Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.

Int J Dermatol. 2009 Jul;48(7):731-3. doi: 10.1111/j.1365-4632.2009.03910.x.

Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.

J Dtsch Dermatol Ges. 2023 Mar;21(3):295-297. doi: 10.1111/ddg.14980. Epub 2023 Feb 28.

[Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].

Ann Dermatol Venereol. 1992;119(8):563-5.

Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.

Clin Exp Dermatol. 2003 Mar;28(2):163-6. doi: 10.1046/j.1365-2230.2003.01185.x.

Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.

Br J Dermatol. 2013 Jul;169(1):208-10. doi: 10.1111/bjd.12272.

Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.

Int J Dermatol. 2009 Jun;48(6):588-91. doi: 10.1111/j.1365-4632.2009.04006.x.

Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.

Acta Derm Venereol. 2003;83(3):225-6. doi: 10.1080/00015550310007283.

引用本文的文献

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.

Orphanet J Rare Dis. 2024 May 21;19(1):206. doi: 10.1186/s13023-024-03190-1.

Integrated Management Strategies for Epidermolysis Bullosa: Current Insights.

Int J Gen Med. 2022 May 24;15:5133-5144. doi: 10.2147/IJGM.S342740. eCollection 2022.

Transcriptome-Guided Drug Repurposing for Aggressive SCCs.

Int J Mol Sci. 2022 Jan 17;23(2):1007. doi: 10.3390/ijms23021007.

Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.

Acta Derm Venereol. 2021 Aug 24;101(8):adv00523. doi: 10.2340/00015555-3875.

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa.

Orphanet J Rare Dis. 2019 Dec 3;14(1):278. doi: 10.1186/s13023-019-1262-7.

Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Int J Mol Sci. 2019 Nov 14;20(22):5707. doi: 10.3390/ijms20225707.